Literature DB >> 10424996

Cardiopulmonary bypass reduces pulmonary surfactant activity in infants.

M Griese1, C Wilnhammer, S Jansen, C Rinker.   

Abstract

OBJECTIVE: Infants younger than 1 year of age undergoing cardiopulmonary bypass surgery often have severe lung injury necessitating increased postoperative respiratory mechanical support. Inasmuch as the mechanisms may involve an impairment of the pulmonary surfactant system, our aim was to determine whether changes of surfactant occur in such infants.
METHODS: From the day of the operation to day 7 after the operation, serial tracheobronchial small-volume lavages of 19 infants (aged 166 +/- 29 days) were fractionated into a small and a large surfactant aggregate fraction and compared with those of 13 infants without lung disease (aged 203 +/- 33 days).
RESULTS: After cardiac operations with cardiopulmonary bypass surgery, total protein in lavages was increased 3-fold to 4-fold and decreased linearly with time. Surfactant protein A was increased on day 1 and day 2 and then decreased, whereas surfactant protein B and total phospholipids were increased on day 1. The ratio of phospholipids in small and large surfactant fractions was unchanged, but the surface activity of the large-aggregate surfactant was impaired on days 1 to 3.
CONCLUSIONS: Lung injury in infants after cardiopulmonary bypass surgery involves significant biochemical and functional disturbances of the pulmonary surfactant system. Inasmuch as substitution with natural surfactant might correct these deficiencies, the potential of this approach to reduce postoperative morbidity needs to be investigated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424996     DOI: 10.1016/S0022-5223(99)70213-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Influence of the type of congenital heart defects on epithelial lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Manuela Simonato; Aldo Baritussio; Virgilio P Carnielli; Luca Vedovelli; Gianclaudio Falasco; Michele Salvagno; Massimo Padalino; Paola Cogo
Journal:  Pediatr Res       Date:  2018-02-07       Impact factor: 3.756

2.  Surfactant therapy for maternal blood aspiration: an unusual cause of neonatal respiratory distress syndrome.

Authors:  Istemi Han Celik; Gamze Demirel; Fuat Emre Canpolat; Omer Erdeve; Ugur Dilmen
Journal:  Indian J Pediatr       Date:  2011-11-26       Impact factor: 1.967

3.  Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease.

Authors:  Henry H Cheng; Melvin C Almodovar; Peter C Laussen; David Wypij; Angelo Polito; David W Brown; Sitaram M Emani; Frank A Pigula; Catherine K Allan; John M Costello
Journal:  Pediatr Cardiol       Date:  2011-06-29       Impact factor: 1.655

4.  Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation.

Authors:  Steven L Shein; Timothy M Maul; Hong Li; Geoffrey Kurland
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

5.  Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.

Authors:  Christian Stocker; Daniel J Penny; Christian P Brizard; Andrew D Cochrane; Rodrigo Soto; Lara S Shekerdemian
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440

6.  High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery.

Authors:  Onur IsiK; Olcay Murat Disli; Tolga Bas; Hakan AydiN; Murat Koç; Ali Kutsal
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

7.  Surfactant protein B and A concentrations are increased in neonatal pneumonia.

Authors:  Sara D'Aronco; Manuela Simonato; Luca Vedovelli; Aldo Baritussio; Giovanna Verlato; Stefano Nobile; Chiara Giorgetti; Matteo Nespeca; Virgilio P Carnielli; Paola E Cogo
Journal:  Pediatr Res       Date:  2015-06-24       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.